Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Feinberg: IAVI Neutralizing Antibody Consortium |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2017-08-17 |
| Study Made Public: | 2018-11-21 |
Title
Preclinical safety and immunogenicity - BG505 SOSIP.664 gp140/AS01
Description
CAVD 681 (1017-2324) is a preclinical rabbit study evaluating the safety of BG505 SOSIP.664 in combination with AS01B.
Sign in to see full information about this study and to download study data.
Products
Saline (non-specific) AS01B BG505 SOSIP.664Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.